Dose Finding Study of MCI-186 in Acute Ischemic Stroke
| 対象疾患 | Acute Ischemic Stroke |
|---|---|
| 相 | 第2相 |
| スポンサー | Shionogi |
| ステータス | 早期終了 |
| 参加者数 | 17 名 |
| 介入（薬剤） | Continuous infusion high-dose MCI-186, Continuous infusion low-dose MCI-186, Continuous infusion placebo, Approved dosing regimen MCI-186, Approved dosing regimen placebo |
| 開始日 | 2017年11月17日 |
| 完了日 | 2018年5月14日 |
| 結果公開日 | 2025年1月9日 |
概要
To investigate the efficacy and safety of MCI-186 (bolus followed by continuous infusion) in acute ischemic stroke patients through a double-blind, parallel-group comparison with the existing MCI-186 dosing regimen (administration twice daily for 14 days) as the control.
Number of Participants With National Institutes of Health Stroke Scale (NIHSS) Score Improved.
| Continuous Infusion High-dose Group (Group H) | 0 Participants |
|---|---|
| Continuous Infusion Low-dose Group (Group L) | 0 Participants |
| Approved Dosing Regimen Group (Control Group) | 0 Participants |
| Continuous Infusion High-dose Group (Group H) | 2 Participants |
| Continuous Infusion Low-dose Group (Group L) | 0 Participants |
| Approved Dosing Regimen Group (Control Group) | 1 Participants |
BENITIONS で見る ClinicalTrials.gov の原文を見る
同じ疾患の他の治験
- Closed-loop Deep Brain Stimulation to Treat Refractory Neuropathic Pain — Prasad Shirvalkar, MD, PhD
- Women's Health Initiative Strong and Healthy Study — Fred Hutchinson Cancer Center
- Edaravone-Sodium Ozagrel Comparative Post-Marketing Study on Acute Ischemic Stroke — Shionogi
- Zambia Stroke Unit Study — Johns Hopkins University
- Tracking Post-stroke Walking Improvements From the Clinic Into the Home — Western University of Health Sciences
- Improving How Older Adults at Risk for Cardiovascular Outcomes Are Selected for Care Coord — Weill Medical College of Cornell University